Clinical Trials
![A researcher sitting at his desk speaking with a patient.](https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_200_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=DEvDbs9X 200w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_260_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=_e9YHgVz 260w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_320_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=8TCW6xhm 320w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_400_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=FtuG5xpa 400w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_520_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=zDCAY8IC 520w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_640_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=C8qsQM2B 640w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_800_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=-4zaoK1- 800w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_1040_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=uPW31bAN 1040w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_1280_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=_a77bf2s 1280w, https://www.columbiapsychiatry.org/sites/default/files/styles/cola_media_1600_16_9/public/media/images/2018-05/clinicaltrials_3519.jpg?itok=eKqtwSKe 1600w)
The Substance Treatment and Research Service (STARS) of Columbia University Medical Center is the primary site for clinical research on treatments for substance use disorders within the Division. Faculty at STARS conduct cutting-edge clinical research testing potential new treatments. The main focus of STARS research is the development of addiction pharmacotherapy, but behavioral interventions and neuroimaging techniques are studied as well. Treatment of co-occurring psychiatric disorders, such as Attention Deficit/Hyperactivity Disorder and mood disorders, have been a specialized focus of medication treatment development. The source of funding for most clinical trials conducted at STARS is the National Institute of Health, with the balance from private foundations or industry. Studies conducted at STARS have advanced the both the science and clinical application of medication treatment for substance use disorders.
Call 212-923-3031 if you are interested in participating in a research study at STARS.
Faculty Conducting Clinical Trials Research:
Faculty Conducting Clinical Trials elsewhere in the Division: